CMPX
Compass Therapeutics Inc.
NASDAQ: CMPX · HEALTHCARE · BIOTECHNOLOGY
$1.77
+5.99% today
Updated 2026-04-30
Market cap
$300.75M
P/E ratio
—
P/S ratio
269.28x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$2 – $7
Volume
6.9M
Compass Therapeutics Inc. (CMPX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $64.63M | $30.38M | $51.91M | $153.76M | $199.65M | $156.88M | $140.40M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $58.88M | $26.24M | $50.20M | $147.10M | $194.79M | $153.88M | $132.75M |
| Total liabilities | $149.40M | $148.98M | $11.97M | $13.68M | $18.01M | $8.34M | $15.17M |
| Current liabilities | $8.46M | $9.82M | $10.10M | $10.63M | $16.17M | $7.80M | $8.87M |
| Long-term debt | $11.06M | $9.29M | $1.87M | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-87.16M | $-121.91M | $-151.41M | $-233.59M | $-272.81M | $-315.31M | $-364.68M |
| Accounts receivable | — | — | — | — | $320000.00 | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |